Prof. Christoph Lange of the University of Lübeck, Germany is joined by Prof. Raquel Duarte - Head of ERS Assembly 10: Respiratory infections - to discuss the updated ATS/CDC/ERS/IDSA clinical practice guideline on treatment of drug-susceptible and drug-resistant tuberculosis.

ERS, alongside the American Thoracic Society (ATS), the U.S. Centers for Disease Control and Prevention (CDC) and Infectious Diseases Society of America (IDSA) have updated clinical practice guidelines for TB treatment in children and adults in settings in which mycobacterial cultures, molecular and phenotypic drug susceptibility tests and radiographic studies, among other diagnostic tools, are available on a routine basis.

View the updated guideline.